PMID: 9653176Jul 8, 1998Paper

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

Proceedings of the National Academy of Sciences of the United States of America
A J HampsonD Wink

Abstract

The neuroprotective actions of cannabidiol and other cannabinoids were examined in rat cortical neuron cultures exposed to toxic levels of the excitatory neurotransmitter glutamate. Glutamate toxicity was reduced by both cannabidiol, a nonpsychoactive constituent of marijuana, and the psychotropic cannabinoid (-)Delta9-tetrahydrocannabinol (THC). Cannabinoids protected equally well against neurotoxicity mediated by N-methyl-D-aspartate receptors, 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid receptors, or kainate receptors. N-methyl-D-aspartate receptor-induced toxicity has been shown to be calcium dependent; this study demonstrates that 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid/kainate receptor-type neurotoxicity is also calcium-dependent, partly mediated by voltage sensitive calcium channels. The neuroprotection observed with cannabidiol and THC was unaffected by cannabinoid receptor antagonist, indicating it to be cannabinoid receptor independent. Previous studies have shown that glutamate toxicity may be prevented by antioxidants. Cannabidiol, THC and several synthetic cannabinoids all were demonstrated to be antioxidants by cyclic voltametry. Cannabidiol and THC also were shown to prevent hydroper...Continue Reading

References

Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·P ConsroeK Schram
Sep 13, 1991·Journal of Immunological Methods·N W RoehmA L Glasebrook
Mar 1, 1980·Ophthalmology·J C MerrittS S Gelbart
Sep 15, 1995·Annals of the New York Academy of Sciences·A Biegon
Sep 5, 1995·European Journal of Pharmacology·N EshharA Biegon
Jan 1, 1995·Life Sciences·A AbrahamovR Mechoulam
Sep 1, 1996·Neurochemistry International·D L DeupreeJ Y Wu
Jan 1, 1996·Journal of Biochemical Toxicology·F W Berman, T F Murray
Jul 1, 1997·Journal of Neurophysiology·W TwitchellK Mackie
Feb 7, 1998·Journal of Neurochemistry·A J HampsonP E Bickler

❮ Previous
Next ❯

Citations

Oct 7, 2003·Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society·Linda A Parker, Raphael Mechoulam
Jul 2, 2003·Neurotoxicity Research·Mario van der SteltHarald S Hansen
Jan 4, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Giuseppe EspositoTeresa Iuvone
Feb 21, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Markus KathmannEberhard Schlicker
Feb 8, 2008·Neurosurgical Review·Ramazan DurmazAmselem Shimon
May 16, 2006·Cellular and Molecular Neurobiology·Angela Alsasua del Valle
Nov 6, 2010·Cellular and Molecular Neurobiology·Anastasia BologovYosef Sarne
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Allyn C HowlettDerek C Norford
Aug 19, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Shuxian HuRobert Bryan Rock
Mar 9, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Slava Rom, Yuri Persidsky
Mar 13, 2008·Current Treatment Options in Neurology·Gregory T CarterJohn D England
Oct 24, 2007·Molecular Neurobiology·R Mechoulam, E Shohami
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Gregory I LiouAhmed S Ibrahim
May 19, 2009·Neuroscience Bulletin·Zhao-Hui GuoWei-Zhi Wang
May 17, 2005·Journal of the Neurological Sciences·Samuel J JacksonDavid Baker
Dec 31, 2002·Chemistry and Physics of Lipids·R K Razdan, A Mahadevan
Dec 31, 2002·Chemistry and Physics of Lipids·Herbert SchuelAndrea Giuffrida
Dec 31, 2002·Chemistry and Physics of Lipids·Elena GrigorenkoSam Deadwyler
Apr 29, 2000·Prostaglandins & Other Lipid Mediators·G KunosJ A Wagner
Jul 13, 2001·Pharmacology & Therapeutics·A C Porter, C C Felder
Aug 17, 2002·Pharmacology & Therapeutics·Julián RomeroJavier Fernández-Ruiz
Aug 17, 2002·Pharmacology & Therapeutics·Manuel GuzmánIsmael Galve-Roperh
Jun 28, 2003·Brain Research. Molecular Brain Research·José Martínez-OrgadoM Paz Viveros
Jun 1, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·M Glass
Feb 1, 2000·Neuroscience Letters·A D SinorD A Greenberg
Jul 18, 2002·Toxicology Letters·Theodore A SarafianMichael D Roth
Jul 11, 2002·Free Radical Biology & Medicine·Christian Behl, Bernd Moosmann
Jan 30, 2002·Trends in Molecular Medicine·Raphael MechoulamEsther Shohami
Dec 9, 2003·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Olov NilssonChristopher J Fowler
Oct 13, 2000·Organic Letters·S Tchilibon, R Mechoulam
Nov 20, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sagnik BhattacharyyaPhilip K McGuire

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.